PrognosDx Health Announces Appointments of Dr. Garry Nolan to Board of Directors and Dr. Joseph Presti to Scientific Advisory Board

PALO ALTO, Calif.--(BUSINESS WIRE)--PrognosDx Health, Inc., an epigenetics pioneer harnessing the predictive power of global patterns of histone modifications, announced today the appointment of Garry P. Nolan, Ph.D. as Vice Chairman.